Incyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 3.5 % Subordinated Convertible Note due 2011 1,422,000 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,851 $3.61 $6,675
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 89,241 $3.61 $321,803
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,927 $3.61 $6,949
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 22,000 $5.61 $123,420
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 7,772 $3.61 $28,026
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 412,000 $5.61 $2,311,320
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 3.5% Subordinated Convertible Note due 2011 248,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 3.5% Subordinated Convertible Note due 2011 9,068,000 N/A N/A
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 1,000 $11.22 $11,219
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 66,000 $11.22 $740,454
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 228,972 $3.58 $819,720
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 18,000 $11.22 $201,942
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 6,252 $3.58 $22,382
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 2,436,000 $11.22 $27,329,484
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 68,463 $3.58 $245,098
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,628 $3.58 $5,828
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 133 $3.58 $476
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 3.5% Senior Convertible Note due 2011 729,000 $11.22 $8,178,651
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,501 $3.27 $4,911
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 69,566 $3.27 $227,620
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 221,814 $3.27 $725,775
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 6,061 $3.27 $19,832
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 309 $3.27 $1,011
Purchase
METCALF BRIAN W officer: Chief Drug Discovery S..
 Common Stock 5,000 $2.19 $10,925
Purchase
SCHRECK PATRICIA A officer: EVP, General Counsel
 Common Stock 2,500 $2.44 $6,100
Purchase
FRIEDMAN PAUL A director
 Common Stock 13,000 $2.55 $33,124
Purchase
CHARDONNET LAURENT other: Vice President and Treas..
 Common Stock 8,000 $2.71 $21,640
Purchase
HASTINGS DAVID C officer: Chief Financial Officer
 Common Stock 4,000 $2.36 $9,440
Purchase
FRIEDMAN PAUL A director
 Common Stock 5,300 $4.6 $24,380
Purchase
FRIEDMAN PAUL A director
 Common Stock 4,700 $5.35 $25,122
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 864,092 $9 $7,776,828
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 4,997 $9 $44,973
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1,539 $9 $13,851
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 201,648 $9 $1,814,832
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 27,724 $9 $249,516
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 50,000 $5.61 $280,450
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 372,000 N/A N/A
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 592,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 18,612,000 N/A N/A
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 117,000 $11.22 $1,312,623
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 4,000 $11.22 $44,876
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 3.5% Convertible Subordinated Notes due 2011 3,000 $11.22 $33,657
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 1 $10.62 $11
Purchase
14159 CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 7 $10.62 $74
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 223 $10.62 $2,368
Purchase
BAKER BIOTECH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 65 $10.62 $690
Purchase
BAKER / TISCH CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 4 $10.62 $42
Purchase
BAKER BROS. CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 94 $10.99 $1,033
Purchase
BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC director, 10 percent owner
 Common Stock 34,621 $10.99 $380,416

Showing 1200 to 1250 of 1431 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: